Skip to main content
. 2014 Sep 12;13:358. doi: 10.1186/1475-2875-13-358

Table 6.

Multivariate analysis estimating risk of haemoglobin drop from baseline to ≥2 g/dL during different post-treatment follow-up visits

Day 7 (2,657) Day 14 (n=4,638) Day 28 (n=4,082)
OR* (95% CI) p OR*(95% CI) p OR* (95% CI) p
Covariates**
AL 0.51 (0.28-0.90) 0.02 1.33 (0.95-1.87) 0.10 0.86 (0.54-1.39) 0.55
AS+partners 0.70 (0.52-0.94) 0.02 0.95 (0.69-1.32) 0.78 0.96 (0.63-1.44) 0.83
AS 1.36 (0.97-1.92) 0.08 0.99 (0.61-1.59) 0.96 1.07 (0.58-1.96) 0.83
<5 years old 0.87 (0.68-1.11) 0.25 0.82 (0.65-1.04) 0.10 0.82 (0.60-1.12) 0.21
P.f. day 0 1.80 (1.41-2.30 <0.001 1.68 (1.33-2.12) <0.001 1.30 (0.96-.75) 0.09
Treat fail 1.43 (0.88-2.32) 0.15 1.63 (1.13-2.38) 0.01 2.03 (1.44-2.87) <0.001

Note: *OR is the odds ratio obtained from generalized linear and latent mixed model with binomial family using site as random effect;

**Covariates references were: CQ, AQ, SP for day 7 and CQ, AQ, SP and SP-AQ for day 14 and day 28 for treatment, the age ≥ 5 years old for the age group, the 28-day cured parasite outcome after treatment for the treatment failure (Treat fail) outcome, the baseline parasite density was log transformed and treated as continuous variable; AS + partners were: AS-AQ, AS-SP, AS-PYR for day 7, AS-AQ, AS-SP, AS-MEF for day 14 and AS-AQ, AS-SP, AS-PYR, AS-SMP and AS-MEF for day 28.